Skip to main content
SpringerLink
Log in

WHO issues HCV guidelines despite drug cost controversy

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Associate Professor of Medicine at Case Western Reserve University, and Director of Hepatology and Gastroenterology at Louis Stokes Cleveland VA Medical Center

Reference

  • Slomski A. WHO Issues Guidelines on HCV Amid Drug Cost Controversy. JAMA: the Journal of the American Medical Association 311: 2262-3, No. 22, 11 Jun 2014. Available from: URL: http://doi.org/10.1001/jama.2014.5277

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

WHO issues HCV guidelines despite drug cost controversy. PharmacoEcon Outcomes News 706, 4 (2014). https://doi.org/10.1007/s40274-014-1343-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1343-8

Search

Navigation